 |
|
Fear of insurance rejection deters potentially life saving genetic tests for bowel cancer
September 08, 2009An Australian study of families with genetic risk of bowel cancer has found that 50 percent of participants declined genetic testing when informed of insurance implications.
"This indicates that people have a significant fear of insurance discrimination which impacts their decision to have potentially life saving genetic testing," says co-lead author Dr Louise Keogh, of the University of Melbourne's Key Centre for Women's Health in Society.
The population-based study was led by researchers from the University of Melbourne and the Cancer Council Victoria, and published in the prestigious Medical Journal of Australia today.
Researchers identified 106 people from 25 families in which there were genetic mutations that increase the risk of bowel cancer. All were offered the chance to learn their own individual genetic information at a Familial Cancer Clinic.
"When we told participants about the life insurance implications of genetic testing, the number declining genetic testing more than doubled from 20 per cent to 50 per cent," Dr Keogh said.
"In Australia, while genetic information has no implications for health insurance, it can affect life, trauma, disability and sickness and accident insurance policies, "says co-lead author Christine van Vliet, School of Medical Sciences, University of New South Wales.
"However this is not the case in all countries. Since we know all people have some genes which predispose to disease, it is important that the Australian life insurance industry does not deter people from learning about their genetic risks," she says.
Bowel cancer is the second most common cancer for men and women in Australia. One in every 3,000 Australians carry a genetic mutation that places them at high risk of bowel cancer.
"For those at high genetic risk, screening for and removal of polyps reduces the risk of bowel cancer by more than 50 percent," says Associate Professor Mark Jenkins of the University of Melbourne's School of Population Health and senior author on the paper.
"Insurance-related apprehension about genetic testing could have troubling public health consequences. Screening people at high genetic risk of bowel cancer is a highly cost effective way to reduce deaths due to bowel cancer," he says.
Dr Louise Keogh says that now that we know insurance policies are adversely affecting health decision-making, it is time to act.
"We call on the Federal Government and the Australian insurance industry to look at what other countries have done and reconsider the use of genetic information where genetic testing has the potential to reduce morbidity and mortality," she says.
People with a strong family history of bowel cancer and concerned about the possibility of having inherited a high risk can obtain a referral from a GP to visit a Family Cancer Clinic.
University of Melbourne
Researchers identified 106 people from 25 families in which there were genetic mutations that increase the risk of bowel cancer. All were offered the chance to learn their own individual genetic information at a Familial Cancer Clinic.
"When we told participants about the life insurance implications of genetic testing, the number declining genetic testing more than doubled from 20 per cent to 50 per cent," Dr Keogh said.
"In Australia, while genetic information has no implications for health insurance, it can affect life, trauma, disability and sickness and accident insurance policies, "says co-lead author Christine van Vliet, School of Medical Sciences, University of New South Wales.
"However this is not the case in all countries. Since we know all people have some genes which predispose to disease, it is important that the Australian life insurance industry does not deter people from learning about their genetic risks," she says.
Bowel cancer is the second most common cancer for men and women in Australia. One in every 3,000 Australians carry a genetic mutation that places them at high risk of bowel cancer.
"For those at high genetic risk, screening for and removal of polyps reduces the risk of bowel cancer by more than 50 percent," says Associate Professor Mark Jenkins of the University of Melbourne's School of Population Health and senior author on the paper.
"Insurance-related apprehension about genetic testing could have troubling public health consequences. Screening people at high genetic risk of bowel cancer is a highly cost effective way to reduce deaths due to bowel cancer," he says.
Dr Louise Keogh says that now that we know insurance policies are adversely affecting health decision-making, it is time to act.
"We call on the Federal Government and the Australian insurance industry to look at what other countries have done and reconsider the use of genetic information where genetic testing has the potential to reduce morbidity and mortality," she says.
People with a strong family history of bowel cancer and concerned about the possibility of having inherited a high risk can obtain a referral from a GP to visit a Family Cancer Clinic.
University of Melbourne
Bowel Cancer Current Events and Bowel Cancer News RSS'Junk DNA' could spotlight breast and bowel cancer
Scientists at The University of Nottingham have found that a group of genetic rogue elements, produced by DNA sequences commonly known as 'junk DNA', could help diagnose breast and bowel cancer. Their research, funded by Cancer Research UK, is published in this month's Genomics journal.
Alcohol and smoking are key causes for bowel cancer
A new global study has found that lifestyle risk factors such as alcohol consumption and cigarette smoking are important risk factors for bowel cancer.
Germany: Colonoscopy prevents 15,000 cancer cases
Since 2002, statutory health insurances in Germany have offered an endoscopic examination of the colon (colonoscopy) free of charge for all insured persons from the age of 55. Germany was the first country to make nationwide endoscopic screening for bowel cancer a part of its statutory early cancer detection program.
Stem cells: Deathly awakening by interferon
After injuries with blood loss, the body quickly needs to restore the vital blood volume. This is accomplished by a special group of stem cells in the bone marrow.
Screening for colorectal cancer detects unrecognized disease
Screening for colorectal cancer detects four out of ten cancers and should be carefully designed to be more effective, according to a study published today on bmj.com.
Bowel cancer indicator should lead to better treatment
STEM cell scientists have developed a more accurate way of identifying aggressive forms of bowel cancer, which should eventually lead to better treatment and survival rates.
Stem cell indicator for bowel cancer should lead to better survival rates
Stem cell scientists have developed a more accurate way of identifying aggressive forms of bowel cancer, which should eventually lead to better treatment and survival rates. Bowel cancer is the third most common cancer in the UK.
Bowel cancer screening halves emergency admissions and cuts deaths
Bowel cancer screening halves emergency admissions for the disease and significantly cuts death rates, reveal the fifth year results from one of the first UK pilot sites.
Scientists question folic acid fortification
Scientists at the Institute of Food Research have highlighted possible consequences of fortifying flour with folic acid due to new evidence of how it is absorbed by the body.
Mayo Clinic study points to a possible biomarker for colon cancer in people 50 and under
An abnormality of chromosomes long associated with diseases of aging has, for the first time, been linked to colon cancer in people 50 years old and younger, an age group usually considered young for this disease.
More Bowel Cancer Current Events and Bowel Cancer News Articles
 |
Bowel Cancer by Barbara Borwell (Author) Colorectal cancer is one of the most common killers of the 21st century. Bowel Cancer will develop the reader's knowledge and skills in both theory and practice and will enable nurses to demonstrate a good understanding of the problems posed by bowel cancer. This increased awareness provides opportunities for nurses to develop startegies that further enhance the quality and effectiveness of patient care. Acknowledging the vital role of a good working relationship for those engaged in the different aspects of care, the book provides a comprehensive introduction to colorectal cancer for all health professionals. From evolution and treatment to patient and family-centred care, including consideration of an individual's social, spiritual and psychological needs, either in the hospital or the... |
 |
FlameEz-Colon, 60 Capsules/Bottle by FlameEz Inflammatory bowel disease (IBD) is caused by chronic inflammation in digestive tract which leads to severe abdominal pain and diarrhea. Crohn's disease and ulcerative colitis are the most common forms of IBD. Chronic inflammation also plays a significant role in colon cancer. Inflammation promotes oxidative damage, DNA mutation, and cell transformation. Inflammatory mediators act as a tumor promoter, stimulate the proliferation of both untransformed and tumor cells. Tumor cells also amplify inflammatory responses by attracting more inflammatory cells to infiltrate the tumor. Such vicious cycle leads to tissue disruption and metastasis. The importance of inflammation in cancer progression has already led to clinical trials of anti-inflammatory cancer therapy. It is believed that... |
 |
Beyond Medicine - Episode 19 Nurse Marjorie Meckbach was used to caring for others. When her health began to fail, she sank into a depression so deep she could barely take care of herself - until she discovered the healing power of touch. Host Judi Phillips takes a look at the science of Iridology, the eyes are the windows to our health. Also, an alternative approach to constipation. |
 |
How does it feel?: Reflections on a year in the life of one woman, following a diagnosis of bowel cancer by Ann Watts (Author) "What are you going to do now?" my teacher colleagues asked, as I packed away my things after my retirement party. I replied, "I might like to write a book"- never guessing that the subject of the book was going to be - bowel cancer. It was only three days later that I received my diagnosis. "How does it feel?" (reflections on a year in the life of one woman following a diagnosis of bowel cancer), is a moving story of Ann's battle with bowel cancer, through surgery and chemotherapy. It includes a journal which describes the day to day ups and downs of illness; and also an anthology of pictures and poems through which Ann expresses her inner journey. This book will provide encouragement to all who suffer from cancer. Ann's story is told with honesty and directness and this book... |
 |
Coping With Bowel Cancer (Overcoming Common Problems) by Tom Smith (Author) Doctors today can offer more hope than ever before. The last 10 years have seen huge strides in medical knowledge of this very common cancer, with improved chances of survival after diagnosis. This books looks at screening, symptoms, treatment, and lifestyle advice, as well as drugs and surgery of the future. Its aim is to offer hope to people who know that they have the disease, for those caring for bowel cancer sufferers, and for those who are at higher than normal risk of the disease. |
 |
Gut-Check: Your Prime Source for Bowel Health and Colon Cancer Prevention by Jeffrey M. Aron (Author), Harriette E. Aron (Author) Not just another diet or exercise book, but a unique reference tool that discusses a difficult subject with wisdom and wit and provides concise, expert information on how to optimize bowel function, prevent disease, and achieve great health. |
 |
Your Guide to Bowel Cancer (Royal Society of Medicine) by John Northover (Author) The Royal Society of Medicine's Your Guide to Bowel Cancer is the patient's ultimate tool to understanding their illness, discovering valuable advice, and empowering them to make informed choices and to regain control of their life. Written by the top UK expert in this field, this is an easy-to-use guide to bowel cancer- most importantly explaining how to recognize the symptoms and seek treatment for this eminently curable but little discussed condition. The book explains the structure of the bowel and the nature of cancer, before outlining what the symptoms are and when to go and seek help. It will then acompany the patient and carer every step of the way, through different treatment and surgical options all the way to after-care and rehabilitation. Fully endorsed and supported by... |
 |
***** NEW GLASS Bottles! ***** Set 0f 3 ~ Dr. Schulze's Intestinal Formula #1 Colon Bowel Cleanse 90 Cap Bottles *****SAVE on 3 Bottles***** by AMERICAN BOTANICAL PHARMACY |
 |
Xango Juice-Mangosteen Juice Drink, 4 Bottles by Xango A delicious dietary supplement, XanGoTM Juice harnesses the nutritional power of the whole mangosteen fruit through a potent proprietary formula. Just one to three ounces each day unleashes a concentrated rush of xanthonesa vigorous family of phytonutrients. The best part: sensational flavor thatll keep you coming back for more and more. XanGo ensures exceptional product quality standards from the mangosteen tree to the bottle of XanGoTM Juice. Each bottle meets strict ISO standards and passes hundreds of quality tests before the premium dietary supplement is served to consumers worldwide. XanGo Juice boasts a proprietary wholefruit formula, harnessing a concentrated rush of xanthonesa vigorous family of nextgeneration phytonutrients. Sounds complex. But heres the straight scoop.... |
|
Cancer of the Large Bowel (Clinical cancer monographs) by Geoffrey Slaney (Author), J Powell (Author), C.C. McConkey (Author) Part of a series presenting the data compiled by the West Midlands Regional Cancer Registry, by site of infection. It presents and analyzes data, not just on incidence, but also on treatments and the effect of treatments on survival. The records used in the analysis cover a population of 5 million people, with demographic characteristics which serve as a model for other regions in industrialized countries, over a 25-year period. The series is designed to be of value to oncologists, clinicians, health planners and medical statisticians. |
| © 2010 BrightSurf.com |